BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Tecan Announces Another Major OEM Agreement With A Leading Diagnostics Company For Development And Supply Of A Dedicated Diagnostics Instrument


5/31/2011 8:58:38 AM

MANNEDORF, SWITZERLAND--(Marketwire - May 30, 2011) - Tecan Group AG / Tecan announces another major OEM agreement with a leading diagnostics company for development and supply of a dedicated diagnostics instrument . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.

* Program already in advanced development phase * Shipment of serial units for the start of the commercial launch expected within the next 24 months * Sales potential is estimated to be more than CHF 100 million over the first five years after launch

Männedorf, Switzerland, May 30, 2011 - The Tecan Group (SIX: TECN) today signed a major OEM agreement with a global leader in a fast growing field of diagnostics for the development and supply of a dedicated diagnostics instrument. Under the agreement, Tecan will develop and supply an instrument to be used in conjunction with diagnostic tests developed by the partner. The diagnostics company is a new OEM customer for Tecan.

Development of the dedicated instrument had started with a joint concept development. Feasibility testing was successfully completed and the program currently is in an advanced development stage. The development is fully funded by the diagnostics company.

In addition to the development agreement both companies signed a supply agreement with minimum purchase volumes scheduled over several years. Upon successful completion of development, based on Tecan's expectations the sales potential is estimated to be more than CHF 100 million over the first five years after launch. Tecan expects to ship the first serial units of the instrument for the start of the commercial launch to the diagnostics company within the next 24 months.

Thomas Bachmann, CEO of Tecan, said: "We are delighted to have signed a second major OEM agreement within the last six months for the development and supply of a dedicated diagnostics instrument. Our strong track record in the industrialization of R&D projects, specific know-how in automating many of the steps required, existing hardware and software elements and the dedication of the Tecan team significantly accelerate the whole process from development to launch. For Tecan the agreement with this new OEM partner has the potential to become one of the most significant OEM agreements signed so far."

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 12100191.

ISIN: CH0012100191;

Press Release (PDF): http://hugin.info/100384/R/1516473/456253.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Tecan Group AG via Thomson Reuters ONE

[HUG#1516473]


or further information:
Tecan Group
Martin Braendle
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
Email Contact
www.tecan.com



Read at BioSpace.com

Tecan
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES